Figure 1.

Using transcriptomic data to accurately identify IOC and LMP. (A) The clinically/pathologically defined IOC and LMP, as well as patient transcriptomic data were reanalysed using PCA analysis. (B) Hierarchical clustering was employed to classify the clinically/pathologically defined IOC and LMP. The dataset used in this figure was GSE12172, which contained 60 IOC and 30 LMP samples. IOC, invasive epithelial ovarian cancer; LMP, low malignant potential ovarian tumour; PCA, principal component analysis